1. All Products
  2. TENOFOVIR DISOPROXIL fumarate 300mg, eq. 245mg base, tab.
Public Pricelist

TENOFOVIR DISOPROXIL fumarate 300mg, eq. 245mg base, tab.

https://medicalguidelines.msf.org/en/node/646
https://unicat.msf.org/cat/product/12321
STD DORATENO3T-

Valid Article

Former Code(s): DORAMISC426 DORAZBD0426
6.4.2.1 - Nucleoside/Nucleotide reverse transcriptase inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
6.4.4.1.1 - Nucleoside/Nucleotide reverse transcriptase inhibitors
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AF07
Anatomical Therapeutic Chemical Classification according to WHOCC
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

TENOFOVIR (TDF)

Therapeutic Action

Antiretroviral, nucleotide reverse transcriptase inhibitor (NRTI)

Indications

Chronic hepatitis B

No longer recommended for HIV treatment: replaced by FDCs.

Instructions for use

300 mg tenofovir fumarate is equivalent to 245 mg tenofovir base.

For HIV treatment, use fixed-dose combinations containing tenofovir.

Storage

Below 25ºC